Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01674608
Other study ID # ICF
Secondary ID
Status Completed
Phase N/A
First received August 14, 2012
Last updated May 4, 2015
Start date July 2012
Est. completion date March 2014

Study information

Verified date May 2015
Source Australian and New Zealand Intensive Care Research Centre
Contact n/a
Is FDA regulated No
Health authority Australia: Human Research Ethics Committee
Study type Observational

Clinical Trial Summary

Patients in the Intensive Care Unit (ICU) traditionally receive bed rest as part of their care. They develop muscle weakness even after only a few days of mechanical ventilation that may prolong their time in ICU and in hospital, but the nature of such weakness is poorly understood.

The weakness that develops in ICU is more substantial than that which would result from bed rest alone and is referred to as ICU acquired weakness (ICUAW). This weakness might be due to the combination of inflammation and immobility. The exact mechanisms leading to the nerve and muscle damage which occurs in critical illness are not yet fully understood and require further investigation. However, it is known that ICUAW has an effect on a patient's ability to breathe without a ventilator, walk and perform simple activities (like washing and toileting) and often results in longer mechanical ventilation time and hence, longer hospital stays than might otherwise be expected. It may also affect a patient's ability to return home after their hospital stay. The recovery period in Australian and New Zealand ICU patients is unknown but a trial from Canada has reported ongoing weakness five years after leaving ICU. Weakness in survivors of intensive care is known to be a substantial problem. It is currently not known whether ICUAW may be avoided or its severity reduced with simple strategies of early exercise in ICU.

There are no data about the level of activity and mobility in critically ill patients in Australian and New Zealand ICUs. These data are urgently required to plan a program of research to test whether increasing the level of mobility and activity in our critically ill patients is safe, feasible and efficacious in terms of reducing the severity of ICUAW and improving patient-centred outcomes. The program of research will first include a study to observe the mobility levels in 25 ICUs across Australia and New Zealand to determine safety, barriers to mobility and what type of activities are undertaken by our patients.

From the observational data we plan to develop a pilot randomised controlled trial of early mobility and activity in intensive care units across Australia and New Zealand. This simple, cost-effective strategy may improve functional ability, decrease time on mechanical ventilation and improve long term outcomes in this patient group. By initiating such a program, ANZ investigators might be able to change future patient outcomes worldwide.


Recruitment information / eligibility

Status Completed
Enrollment 192
Est. completion date March 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- they have received invasive mechanical ventilation for at least 24 hours, and have been in ICU less than 72 hours

- the treating clinician expects the patient to still be receiving invasive mechanical ventilation in the ICU the day after tomorrow.

Exclusion Criteria:

- Age less than 18 years old

- Patient has a proven or suspected acute primary brain process that is likely to result in global impairment of conscious level or cognition, such as traumatic brain injury, intracranial haemorrhage, stroke, or hypoxic brain injury after cardiac arrest or asphyxiation.

- Second or subsequent admission to ICU during a single hospital admission

- Patient does not speak English

- Patient has proven or suspected primary myopathic or neurological process associated with prolonged weakness, such as Guillain-Barre syndrome

- Death is deemed imminent and inevitable

- Inability to walk without assistance prior to the acute illness that is associated with admission to ICU (use of a cane or walker not an exclusion)

- Cognitive impairment prior to the acute illness that is associated with admission to ICU (refer data dictionary)

- Any written "Rest In Bed" or non-weight bearing medical order such as may occur with hip fracture, unstable spine or pelvis, pathological fracture

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Australia The Alfred Melbourne Victoria
New Zealand Wellington hospital Wellington

Sponsors (2)

Lead Sponsor Collaborator
Australian and New Zealand Intensive Care Research Centre Intensive Care Foundation, Australia

Countries where clinical trial is conducted

Australia,  New Zealand, 

References & Publications (1)

TEAM Study Investigators, Hodgson C, Bellomo R, Berney S, Bailey M, Buhr H, Denehy L, Harrold M, Higgins A, Presneill J, Saxena M, Skinner E, Young P, Webb S. Early mobilization and recovery in mechanically ventilated patients in the ICU: a bi-national, m — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Best level of activity in ICU Highest level of activity (11 point scale) including:
unknown nothing (lying in bed, passive stretches) sitting in bed, active exercises in bed moved to chair (via hoist, slide etc but no standing) sitting over edge of bed standing transferring bed to chair marching on spot (at bedside) walking with assistance of 2 or more people walking with assistance of 1 person walking independently with a gait aid walking independently without a gait aid
ICU stay (average 7 days) No
Primary Dosage of the best level of activity The time spent performing the best level of activity and the number of times it is achieved Intensive care unit stay (average 7 days) No
Primary Time to standing in ICU The number of days in ICU before a patient can stand Intensive care stay (average 7 days) No
Secondary Best level of activity at hospital discharge Highest level of activity (11 point scale) including:
unknown nothing (lying in bed, passive stretches) sitting in bed, active exercises in bed passively moved to chair (pat slide, hoist but no standing) sitting over edge of bed standing transferring bed to chair marching on spot (at bedside) walking with assistance of 2 or more people walking with assistance of 1 person walking independently with a gait aid walking independently without a gait aid
Hospital stay (median days 14) No
Secondary Time to first sit out of bed The number of days until the patient can sit out of bed ICU stay (average 7 days) No
Secondary Barriers to mobilisation Factors that may have been a barrier to mobilizing patients in the ICU Intensive care unit stay (average 7 days) No
Secondary Mobilization related adverse events Adverse events that occured during patient mobilization such as an unplanned extubation or a fall to the floor Intensive care unit stay (average 7 days) Yes
Secondary Time to first physiotherapy The number of days in intensive care before the patient was reviewed by a physiotherapist Intensive care unit stay (average 7 days) No
Secondary Mechanical ventilation free days The number of mechanical ventilation free days to day 28 28 days No
Secondary Intensive care unit free days The number of days the patient spent out of ICU to day 28 (if dead = 0) Day 28 No
Secondary 90 day mortality The mortality at day 90 90 days No
Secondary Health related quality of life at 6 months Health related quality of life reported via telephone interview at 6 months using the EuroQoL EQ5D 6 months No